Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FASTKD2 is a mitochondrial RNA-binding protein required for proper processing of mitochondrial transcripts and assembly of the mitochondrial large ribosomal subunit. It interacts with specific mitochondrial RNAs—including 16S ribosomal RNA and ND6 messenger RNA—and is essential for the translation of mitochondrial-encoded proteins and maintenance of respiratory chain complexes. FASTKD2 deficiency causes aberrant RNA processing, impaired mitochondrial translation, and reduced cellular respiration, leading to mitochondrial encephalomyopathy and oxidative phosphorylation deficiencies. Mutations in FASTKD2 result in complex clinical syndromes, with tissue-specific effects that may be partially compensated by other mitochondrial proteins. FASTKD2 is a member of the FASTK family and is defined by several domains of unknown function, including possible RNA-binding motifs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAST kinase domain-containing protein 2, mitochondrial (FASTKD2).